Credit Suisse’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-254,090
Closed -$9.57M 3779
2021
Q1
$9.57M Buy
254,090
+233,124
+1,112% +$8.78M ﹤0.01% 1193
2020
Q4
$357K Buy
+20,966
New +$357K ﹤0.01% 3088
2019
Q4
Sell
-24,513
Closed -$95K 3635
2019
Q3
$95K Sell
24,513
-7,849
-24% -$30.4K ﹤0.01% 3300
2019
Q2
$195K Buy
32,362
+6,406
+25% +$38.6K ﹤0.01% 3207
2019
Q1
$349K Sell
25,956
-1,831
-7% -$24.6K ﹤0.01% 2957
2018
Q4
$258K Buy
27,787
+4,666
+20% +$43.3K ﹤0.01% 3051
2018
Q3
$321K Sell
23,121
-18,508
-44% -$257K ﹤0.01% 3020
2018
Q2
$658K Sell
41,629
-4,810
-10% -$76K ﹤0.01% 2840
2018
Q1
$798K Buy
46,439
+10,526
+29% +$181K ﹤0.01% 2711
2017
Q4
$786K Sell
35,913
-51,214
-59% -$1.12M ﹤0.01% 2690
2017
Q3
$3.57M Sell
87,127
-2,044
-2% -$83.7K ﹤0.01% 1688
2017
Q2
$2.69M Sell
89,171
-18,622
-17% -$561K ﹤0.01% 1728
2017
Q1
$3.9M Buy
107,793
+31,740
+42% +$1.15M ﹤0.01% 1568
2016
Q4
$3.81M Sell
76,053
-643
-0.8% -$32.2K ﹤0.01% 1611
2016
Q3
$4.03M Buy
76,696
+12,325
+19% +$647K ﹤0.01% 1588
2016
Q2
$2.66M Buy
64,371
+4,352
+7% +$180K ﹤0.01% 1881
2016
Q1
$2.44M Buy
60,019
+51,067
+570% +$2.08M ﹤0.01% 1832
2015
Q4
$371K Sell
8,952
-4,572
-34% -$189K ﹤0.01% 3347
2015
Q3
$208K Sell
13,524
-45,073
-77% -$693K ﹤0.01% 3694
2015
Q2
$1.46M Buy
58,597
+17,807
+44% +$442K ﹤0.01% 2596
2015
Q1
$932K Buy
40,790
+21,753
+114% +$497K ﹤0.01% 2778
2014
Q4
$514K Buy
+19,037
New +$514K ﹤0.01% 3335